2022年至2024年,中国东部艾滋病毒耐药性的网络动力学和进化驱动因素
Dongqing Cao1, Hui Xing2, Yi Feng2
1Shaoxing Center for Disease Control and Prevention, Shaoxing 312000, China.
Viruses
|November 27, 2025
概括
艾滋病毒耐药性是一个越来越令人担忧的问题. 这项研究在中国绍兴发现了14.4%的治疗前耐药性 (PDR),具有与传播群和治疗失败相关的特定突变.
科学领域:
- 流行病学 流行病学
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 艾滋病毒耐药性是全球重大健康挑战.
- 了解耐药性模式对于有效的治疗策略至关重要.
- 在中国东部艾滋病毒耐药性的流行和特征需要调查.
研究的目的:
- 在中国东部的绍兴调查预治疗药物耐药性 (PDR) 和获得药物耐药性的流行病学动态.
- 描述耐药性HIV菌株的分子特征.
- 确定药物耐药性的传播网络和来源.
主要方法:
- 预期招募571名新诊断的艾滋病毒感染者和119名抗逆转录病毒治疗失败的患者 (2022-2024年).
- 应用分子传播网络分析来识别耐药集群.
- 利用贝叶斯分析来追踪抗性突变的起源.
主要成果:
- 整体PDR患病率为14.4%,非核酸逆转录酶抑制剂 (NNRTIs) 具有最高的耐药性 (9.8%).
- 在CRF07_BC亚型群中发现了关键的耐药性突变 (K103N,Q58E).
- 贝叶斯分析建议在2016-2017年左右从广东省引入耐药性;与新感染有关的治疗失败.
结论:
- 针对特定的艾滋病毒亚型和传播集群需要有针对性的干预措施.
- 持续监测HIV耐药性对于优化抗逆转录病毒疗法 (ART) 至关重要.
- 解决治疗失败对于制耐药性艾滋病毒的传播至关重要.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.1K
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
32.1K
相关概念视频
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
